Buy Rating Maintained for Apellis Pharmaceuticals: Strategic Market Position and Growth Potential Justify Price Objective
Apellis Pharmaceuticals Down Over 14%, on Pace for Largest Percent Decrease Since December 2023 -- Data Talk
Express News | Apellis Pharmaceuticals Inc - Board Expands to Seven Directors, Six Independent
Express News | Apellis Announces Keli Walbert to Join the Board of Directors
Press Release: Apellis Announces Keli Walbert to Join the Board of Directors
Piper Sandler Remains a Hold on Apellis Pharmaceuticals (APLS)
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
been hot today but that's getting into buying range for me..... EBS middle size company that got a new CEO last year completely changed things around since for EBS. take a look at who owns EBS and how much together. this small float is trading around 50% since half or more is already bought up by insiders or tutes